CLINEXEL
CLINEXEL is a CDSCO-registered, full-service Clinical Research Organization providing clinical development, pharmacovigilance, regulatory affairs, and medical writing services to pharma, biotech, and medical device companies in India, the USA, and Europe.
- Company typePrivate
- Founded2019
- HeadquartersMumbai, India
- Headcount11–50
- GTM typeB2B
- OfferingServices
What CLINEXEL does
CLINEXEL (legal name Clinexel Life Sciences Pvt Ltd) is a CDSCO-registered, full-service Clinical Research Organization (CRO) headquartered in Navi Mumbai, Maharashtra, India, with operating presence in India, the USA, and the UAE. The company delivers end-to-end clinical development services to pharmaceutical, biotechnology, and medical device companies based in India, Europe, the USA, Canada, Israel, and Singapore. Its stated service portfolio spans the full clinical trial lifecycle, including clinical trial management across all phases (I-IV), pharmacovigilance, medical writing, regulatory affairs, data management, biostatistics, pharmacokinetic studies (BA/BE), and medical device clinical studies aligned with EU-MDR and IVDR requirements.
The core product set comprises eleven distinct service modules: Clinical Trials, Pharmacovigilance, Medical Writing, Regulatory Affairs, Medical Devices, Global Clinical Development, Representative Services (local agent/QPPV), Pharmacokinetic Studies, Specialized Safety Services, Data Management, and Biostatistics. Delivery relies on full-time employees (CRAs, monitors, project managers, and medical writers) operating from CLINEXEL offices, supplemented by pre-qualified third-party technology partners providing validated safety databases, EDC systems, eTMF, and QCTMS platforms. Global Clinical Development is enabled through membership in AICROS (Association of International CROs), an alliance of eight local CROs that allows CLINEXEL to act as a local CRO in Multi-Regional Clinical Trials (MRCTs) where it lacks on-ground staff.
CLINEXEL generates revenue through project-based professional services contracts with pharma, biotech, and medical device clients; pricing is determined per scope of work, therapeutic area, trial phase, and geography. The go-to-market motion combines direct enterprise field sales targeting global sponsors, channel partnerships with international CROs through AICROS, and an event-driven presence at major industry conferences (BIO International, CPHI, Arab Health, BIOASIA, DIA KMTC MedTech, Swiss Biotech Day). The company is privately held and founder-led by CEO Dr. Deepa Arora (MBBS, MD; 25+ years across Lupin, Wockhardt, Reliance), with no disclosed external investors or institutional capital.
CLINEXEL firmographics
Firmographics- Name
- CLINEXEL
- Legal name
- Clinexel Life Sciences Pvt Ltd
- Website
- https://clinexel.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- CLINEXEL is a CDSCO-registered, full-service Clinical Research Organization providing clinical development, pharmacovigilance, regulatory affairs, and medical writing services to pharma, biotech, and medical device companies in India, the USA, and Europe.
- Ownership category
- akta.pro rank
CLINEXEL industry classification
Industry- Product category
- Clinical Research Organization (CRO) Services
- NAICS
- Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
Keywords
Where CLINEXEL is headquartered
LocationHeadquarters
- HQ city
- Mumbai
- HQ country
- India
- HQ region
- Asia
Offices1 record
Markets served
CLINEXEL business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Clinical Research Services: Full-service CRO providing end-to-end clinical development services including clinical trials, pharmacovigilance, regulatory affairs, medical writing, data management, biostatistics, and pharmacokinetic studies. Revenue is generated through project-based contracts with pharma, biotech, and medical device companies.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels8 records
CLINEXEL product offering
Product offeringCore offering
CLINEXEL is a full-service Clinical Research Organization (CRO) providing end-to-end clinical development services including clinical trial management (Phases I-IV), pharmacovigilance and drug safety, regulatory affairs (CDSCO, USFDA, EMA submissions), medical writing, data management, biostatistics, pharmacokinetic (BA/BE) studies, and medical device clinical evaluation. Services are delivered by full-time FTE staff including CRAs, monitors, project managers, and medical writers, supported by pre-qualified technology partners for safety databases, EDC, eTMF, and QCTMS platforms.
Product overview
CLINEXEL is a full-service Clinical Research Organization (CRO) providing end-to-end clinical development services. The company operates a platform-plus-services model delivering integrated solutions across the clinical trial lifecycle. Core service modules include Clinical Trials (full-service trial management from protocol to CSR), Pharmacovigilance (drug safety and signal detection), Medical Writing (regulatory and clinical documentation), Regulatory Affairs (CDSCO and international submissions), Medical Devices (device trials and CE marking support), Global Clinical Development (MRCT coordination via AICROS), and Data Management with Biostatistics (CDM and statistical analysis). Supporting specialized services include Pharmacokinetic Studies (BA/BE), Specialized Safety Services, and Representative Services (local agent/QPPV). All services are delivered by full-time FTE staff operating from CLINEXEL offices, supported by pre-qualified technology partners for safety databases, EDC systems, eTMF, and QCTMS.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Trials
Companies that use CLINEXEL
Customer profileSegments3 records
Ideal customer profiles3 records
CLINEXEL technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
CLINEXEL partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- AICROS (Association of International Contract Research Organizations)coreCLINEXEL is a full member of AICROS, an alliance of 8 local and well-established CROs. Through AICROS, CLINEXEL conducts Multi-Region Clinical Trials (MRCTs) in countries where Clinexel staff are not present on the ground. This partnership enables global clinical development capabilities while maintaining local expertise.
- Local CROs (through AICROS network)corePartnership with strong Local CROs through AICROS to conduct clinical trials across the globe. CLINEXEL works closely with these partners as local CRO in Multi-Regional Clinical Trials (MRCTs), handling identification of trial sites, feasibility, site selection, site management, monitoring, and regulatory coordination.
Scale indicators6 records
Recent moves4 records
Expansion highlights5 records
CLINEXEL competitors and assessment
Company assessmentBroad incumbents
- IQVIA: The world's largest CRO with broad clinical, data, and consulting services. IQVIA is the dominant prime CRO competitor for large Phase II–III trials that Clinexel also targets through its AICROS sub-CRO partnerships.
- ICON plc: Global full-service CRO formed from the PRA merger, offering clinical trials, biotech, and consulting services. ICON competes for the same global pharma and biotech sponsors Clinexel serves, but at vastly greater scale.
- Parexel International: Large global CRO with deep Phase II–III and biotech focus. Parexel's biotech-centric positioning overlaps closely with Clinexel's biotech sponsor base.
- Syneos Health: Biopharma solutions organization spanning clinical development and commercialization. Competes in Clinexel's space for biotech and mid-cap pharma sponsors running multi-region trials.
- Labcorp Drug Development (Covance): Global CRO and central laboratory services through Labcorp's Drug Development arm. Overlaps with Clinexel's clinical monitoring, lab, and central lab offerings for global pharma sponsors.
- Eurofins Clinical Trial Services: Global laboratory and CRO services provider covering clinical trials, bioanalytical, and central lab work. Comparable on Phase I–IV bioanalytical/PK capabilities that Clinexel offers for sponsors targeting India.
Direct peers
- Lambda Therapeutic Research: India-headquartered full-service CRO offering BA/BE, Phase I–IV clinical, bioanalytical, and clinical data management services across multiple continents. Operates in essentially the same Indian CRO space with comparable end-to-end services.
- Veeda Clinical Research: India-based CRO specializing in early-phase clinical research, BA/BE, and clinical trial services for pharma and biotech sponsors. Directly comparable on India footprint, therapeutic breadth, and Phase I–IV delivery.
- Accutest Research Laboratories: Indian CRO offering clinical research, BA/BE, bioanalytical, and clinical trial services. Closely comparable Indian-headquartered full-service CRO competing for similar sponsors in the same geographies.
Emerging players
- PharmaLex: Mid-sized consulting and services provider for regulatory affairs, pharmacovigilance, and clinical development. Directly competes with Clinexel's regulatory affairs and PV service lines.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
CLINEXEL social profiles
Digital presenceCLINEXEL compliance and trust
Trust signalCompliance2 records
CLINEXEL financial estimates
Financial estimateRevenue estimate
Valuation estimate
CLINEXEL leadership team
Management profileNumber of profiles
Profiles5 records
CLINEXEL funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CLINEXEL M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CLINEXEL
What does CLINEXEL do?
CLINEXEL is a full-service Clinical Research Organization (CRO) providing end-to-end clinical development services including clinical trial management (Phases I-IV), pharmacovigilance and drug safety, regulatory affairs (CDSCO, USFDA, EMA submissions), medical writing, data management, biostatistics, pharmacokinetic (BA/BE) studies, and medical device clinical evaluation. Services are delivered by full-time FTE staff including CRAs, monitors, project managers, and medical writers, supported by pre-qualified technology partners for safety databases, EDC, eTMF, and QCTMS platforms.
Is CLINEXEL a public or private company?
CLINEXEL is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was CLINEXEL founded?
CLINEXEL was founded in 2019. It employs 11 to 50 people.
Where is CLINEXEL based?
CLINEXEL is headquartered in Mumbai, India, in the Asia region.
How does CLINEXEL make money?
One revenue line is on record: clinical Research Services.
Who are CLINEXEL's main competitors?
Broad incumbents on record are IQVIA, ICON plc, Parexel International, Syneos Health, Labcorp Drug Development (Covance) and Eurofins Clinical Trial Services. Direct peers are Lambda Therapeutic Research, Veeda Clinical Research and Accutest Research Laboratories. PharmaLex is listed as an emerging player.
Does CLINEXEL have an API?
No public API is recorded for CLINEXEL.
What industry is CLINEXEL in?
CLINEXEL's product category is Clinical Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV). Its NAICS code is 54169 and its SIC code is 8731.